4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino-],2S-(2a,5a,6b-,monosodium salt.
Monosodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
[69-57-8].
Packaging and storage
Preserve in tight containers.
Labeling
Where it is intended for use in preparing injectable dosage forms,the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Identification
A:
Infrared Absorption á197Kñ.
B:
It responds to the tests for Sodium á191ñ.
pHá791ñ:
between 5.0and 7.5,in a solution containing 60mg per mL.
Loss on drying á731ñ
Dry about 100mg,accurately weighed,in a capillary-stoppered bottle in vacuum at a pressure not exceeding 5mm of mercury at 60

for 3hours:it loses not more than 1.5%of its weight.
Assay
Mobile phase,Resolution solution,Standard preparation,and Chromatographic system
Proceed as directed in the
Assayunder
Penicillin G Potassium.
Assay preparation
Transfer about 5mg of Penicillin G Sodium,accurately weighed,to a 50-mLvolumetric flask,add about 45mLof water,and shake to dissolve.Dilute with water to volume,and mix.
Procedure
Proceed as directed in the
Assayunder
Penicillin G Potassium.Calculate the potency,in Penicillin G Units per mg,of Penicillin G Sodium taken by the formula:
(PWS/WU)(rU/rS),
in which
WUis the weight of Penicillin G Sodium taken to prepare the
Assay preparation,and the other terms are as defined therein.